129 related articles for article (PubMed ID: 16338010)
1. Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease.
Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
Int J Cardiol; 2006 Nov; 113(2):167-73. PubMed ID: 16338010
[TBL] [Abstract][Full Text] [Related]
2. Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease.
Shimada K; Mokuno H; Matsunaga E; Miyazaki T; Sumiyoshi K; Miyauchi K; Daida H
Atherosclerosis; 2004 Jun; 174(2):343-7. PubMed ID: 15136065
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques.
Anselmi M; Garbin U; Agostoni P; Fusaro M; Pasini AF; Nava C; Keta D; Turri M; Zardini P; Vassanelli C; Lo Cascio V; Cominacini L
Atherosclerosis; 2006 Mar; 185(1):114-20. PubMed ID: 15998517
[TBL] [Abstract][Full Text] [Related]
4. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.
Ndrepepa G; Braun S; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A
Clin Chim Acta; 2005 Oct; 360(1-2):178-86. PubMed ID: 15993392
[TBL] [Abstract][Full Text] [Related]
6. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
[TBL] [Abstract][Full Text] [Related]
7. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris.
Doo YC; Han SJ; Lee JH; Cho GY; Hong KS; Han KR; Lee NH; Oh DJ; Ryu KH; Rhim CY; Lee KH; Lee Y
Am J Cardiol; 2004 Mar; 93(5):554-8. PubMed ID: 14996578
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.
Braun S; Ndrepepa G; von Beckerath N; Mehilli J; Gorchakova O; Vogt W; Schömig A; Kastrati A
Am Heart J; 2005 Sep; 150(3):550-6. PubMed ID: 16169339
[TBL] [Abstract][Full Text] [Related]
9. Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Lindahl B; Lindbäck J; Jernberg T; Johnston N; Stridsberg M; Venge P; Wallentin L
J Am Coll Cardiol; 2005 Feb; 45(4):533-41. PubMed ID: 15708700
[TBL] [Abstract][Full Text] [Related]
10. Association of Plasma Marker of Oxidized Lipid with Histologic Plaque Instability in Patients with Peripheral Artery Disease.
Kim K; Lim C; Kim G; Chung JH; Cho YS; Cho JH; Seo JB; Chung WY; Oh SJ; Choi JS; Kim JS; Park JJ; Suh JW; Youn TJ; Chae IH; Choi DJ
Ann Vasc Surg; 2020 Jul; 66():554-565. PubMed ID: 31706994
[TBL] [Abstract][Full Text] [Related]
11. Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with non-diabetic unstable angina: a potential role in immunologic reaction of plaque instability.
Kwon KH; Kwon HM; Hong BK; Kim DS; Lee JY; Ryu SK; Park BE; Park HY; Kim JH; Yoon YW; Cho SY; Kim HS
Yonsei Med J; 2002 Apr; 43(2):203-10. PubMed ID: 11971214
[TBL] [Abstract][Full Text] [Related]
12. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
Lindahl B; Toss H; Siegbahn A; Venge P; Wallentin L
N Engl J Med; 2000 Oct; 343(16):1139-47. PubMed ID: 11036119
[TBL] [Abstract][Full Text] [Related]
13. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications.
Monaco C; Crea F; Niccoli G; Summaria F; Cianflone D; Bordone R; Bellomo G; Maseri A
Eur Heart J; 2001 Sep; 22(17):1572-7. PubMed ID: 11492986
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up.
Bayés B; Pastor MC; Bonal J; Foraster A; Romero R
Nephrol Dial Transplant; 2006 Apr; 21(4):984-90. PubMed ID: 16326744
[TBL] [Abstract][Full Text] [Related]
16. Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome.
Izar MC; Fonseca HA; Pinheiro LF; Monteiro CM; Póvoa RM; Monteiro AM; Figueiredo-Neto AM; Gidlund MA; Fonseca FA
Diab Vasc Dis Res; 2013 Jan; 10(1):32-9. PubMed ID: 22529217
[TBL] [Abstract][Full Text] [Related]
17. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin.
Matsumoto T; Takashima H; Ohira N; Tarutani Y; Yasuda Y; Yamane T; Matsuo S; Horie M
J Am Coll Cardiol; 2004 Jul; 44(2):451-7. PubMed ID: 15261947
[TBL] [Abstract][Full Text] [Related]
18. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.
Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T
Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816
[TBL] [Abstract][Full Text] [Related]
19. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
[TBL] [Abstract][Full Text] [Related]
20. The complex link between oxidised low-density lipoprotein and unstable angina.
Niccoli G; Mongiardo R; Lanza GA; Ricco A; Burzotta F; Trani C; Mazzari MA; Liuzzo G; Lombardo A; Rebuzzi AG; Holvoet P; Crea F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):387-91. PubMed ID: 17443110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
